Sinopharm
1099.HK
#2278
Rank
A$10.27 B
Marketcap
$3.29
Share price
0.94%
Change (1 day)
-23.79%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total debt

Total debt on the balance sheet as of December 2023 : A$15.65 B

According to Sinopharm's latest financial reports the company's total debt is A$15.65 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Sinopharm - Total debt on balance sheet (from 2008 to 2023)

Total debt by year

Year Total debt Change
2022-12-31A$20.13 B36.46%
2021-12-31A$14.75 B8.22%
2020-12-31A$13.63 B21.43%
2019-12-31A$11.22 B-1.24%
2018-12-31A$11.36 B55.06%
2017-12-31A$7.33 B9.57%
2016-12-31A$6.69 B9.09%
2015-12-31A$6.13 B5.76%
2014-12-31A$5.80 B24.55%
2013-12-31A$4.65 B86.55%
2012-12-31A$2.49 B16.18%
2011-12-31A$2.14 B318.83%
2010-12-31A$0.51 B82.38%
2009-12-31A$0.28 B-18.99%
2008-12-31A$0.34 B-4.57%
2007-12-31A$0.36 B18.98%
2006-12-31A$0.30 B